SB Management Ltd
Regulatory profile
From Form ADV, the SEC filer profile, 13D/13G type codes and N-CEN, never from the name.
Portfolio style
Measured from the filed 13F common-share book for Mar 31, 2022, never from the firm's own description.
Closest benchmark: the Russell 2000 as of 2022-03-31, active share 99.9%; sector active share 55.8% against the combined 13F book's sector weights.
Over time 7 measured quarters
How the bands are measured
Style bands measure the filed 13F common-share book each closed quarter, tested in this order. Unknown: under $10,000,000 of valued equity or 5 stocks. Index-like (100+ stocks): active share of 20% or less against the closest benchmark, which is the S&P 500, S&P MidCap 400, S&P SmallCap 600, Russell 1000, Russell 2000, Nasdaq-100 or Dow Jones Industrial Average (weighted by an index-tracking fund's reported holdings or the index's constituents nearest the quarter end, over the names resolved to companies, and only when those are 90%+ of its weight) or every 13F filer's combined book, or index series holding 80%+ of the registered fund assets it advises (N-CEN) and equal to 50%+ of its book. Systematic-like: 500+ stocks, 100%+ annual turnover and a top 10 weight of 25% or less. Concentrated: a top 10 weight of 60%+ or 12 or fewer effective positions. Diversified active: none of these. Turnover is the smaller of buys and sells over average equity value, summed over four quarters: low under 30%, high 100%+. Horizon is the value-weighted number of quarters each position has been held: short under 4, long 12+.
Clone Performance
Build a hypothetical price-return history from this filer's public 13F holdings.
View clone backtestPortfolio Concentration
8 tracked positions · as of Mar 31, 2022 · Δ vs Dec 31, 2021Portfolio Trend
Sector Breakdown
As of Mar 31, 2022| Sector | % Portfolio | Value |
|---|---|---|
| Unclassified | 58.5% | $228,159,000 |
| Healthcare | 29.7% | $115,738,335 |
| Financial Services | 6.8% | $26,622,000 |
| Industrials | 5.1% | $19,820,000 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increasedTrimmed
Positions the filer reducedNew Positions
Positions the filer opened this quarterSold Out
Positions the filer fully exited| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
|
|
Held | 43,176,600 | $178,319,000 | 45.68% | ||
| ABCL |
AbCellera Biologics Inc.
Healthcare
|
Reduced | 7,764,299 | $75,701,915 | 19.39% | |
|
|
Held | 5,000,000 | $40,000,000 | 10.25% | ||
| AURC |
Better Home & Finance Holding Co
Financial Services
|
Held | 2,700,000 | $26,622,000 | 6.82% | |
| WGS |
GeneDx Holdings Corp.
Healthcare
|
Reduced | 7,450,439 | $22,872,847 | 5.86% | |
| SVFC |
Symbotic Inc.
Industrials
|
Held | 2,000,000 | $19,820,000 | 5.08% | |
| PACB |
Pacific Biosciences Of California, Inc.
Healthcare
|
Reduced | 1,886,107 | $17,163,573 | 4.40% | |
|
|
Held | 1,000,000 | $9,840,000 | 2.52% |
Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.